CD28 and neoplasm: These observations corroborate results from a recent study where cryopreservation of starting material for eventual BCMA-CAR-T cells with a CD28 signaling domain showed decreased IL-2, TNF-α and IFN-γ secretion without affecting anti-tumor function (35).